SGP 株価推移チャート
SGP 財務
SpyGlass Pharma Inc
$0
0%
$0
終値： Aug 24, 16:00:00 GMT-4
$0
0%
$0
アフターマーケット：Aug 24, 20:00:00 GMT-4
戻る
SpyGlass Pharma Inc (SGP) 財務
主要データ
前終値
--
始値
--
当日レンジ
-
52週レンジ
-
取引高
--
平均取引高
--
配当利回り
--
1株当たり利益(TTM)
--
時価総額
--
SGPとは何ですか？
SpyGlass Pharma, Inc. is a late-stage biopharmaceutical, which engages in the development of treatment paradigm for patients living with chronic eye conditions. The company is headquartered in Aliso Viejo, California and currently employs 65 full-time employees. The company went IPO on 2026-02-06. The firm is focused on developing and commercializing long-term, drug delivery solutions for patients suffering from ophthalmic diseases. Its lead product candidate is SpyGlass Drug Delivery Platform with bimatoprost, which is designed to deliver three years of bimotic anti-inflammatory therapy to targeted tissues in the eye.
